When the Human Genome Project concluded 21 years ago, it opened the door for genetic testing and a promise for lifesaving screenings and personalized medicine. An innovation that serves as a key foundation for revolutionizing healthcare also presents significant complexities and challenges.

Explore the latest CIOToday cover story with Rajeev Ronanki.

Getting our population healthier, more equitable, and more access is and has been a vision for years now. Care delivery and payments are on the line in 2024. Will the industry step up and create the tools providers need? Can providers stay relevant without embracing technology solutions? Here is what the experts are seeing in the coming year.

As artificial intelligence (AI) becomes increasingly integral to healthcare, the urgency to integrate ethical governance cannot be overstated.

Early in my career, I felt the pressure to conform — in particular, to present and communicate in ways that weren’t inherently ‘me.’ It was not that effective, and at times could be stifling. Over time, I’ve come to realize that genuine authenticity helps elevate our communication, bolsters our confidence, and enhances our leadership. Embracing and expressing our true selves is irreplaceable.

The second is the use of AI in in the clinical setting where it’s helping doctors be better at their jobs and bringing vast amounts of medical research and options for care right to the fingertips of the clinical community, so they can better serve their patients.

The former chief digital officer explains how IT executives can capitalize on an ongoing sea change between technology and business that, in the age of AI, might be tech chiefs’ finest hour yet.

Digital Transactions recently covered Lyric’s partnership with Codoxo.

Raj Ronanki, CEO, was recently asked for his thoughts on President Biden's Executive Order on Artificial Intelligence.

Lyric to offer Codoxo’s innovative solutions to customers via the LyricIQ ecosystem enabling simple integration and quicker speed to value

Lyric is proud to announce recognition by KLAS Research in the inaugural KLAS Payment Accuracy & Integrity Solutions 2023 Report.

Lyric, an AI-first healthcare technology company, and Autonomize AI, an emerging leader in Generative AI solutions, have announced a strategic partnership designed to enhance healthcare efficiency and transparency. This alliance will bring Autonomize AI's secure, trusted generative AI technology to Lyric’s extensive network of customers.

Lyric, an industry leader in payment accuracy, today announced that Akshay Sharma, Vijay Murugappan, and Yevgeny “Gene” German have joined the company as Chief AI Officer, Chief Commercial Officer, and Chief Product & Technology Officer, respectively.

Lyric, an industry leader in payment accuracy, today unveiled its groundbreaking Artificial Intelligence as a Service (AIaaS) solution, LyriclQ.

Lyric, formerly ClaimsXten Portfolio, has partnered with Concert Genetics (Concert), a leader in end-to-end genetic testing management, to deliver solutions to health plan payers who seek to maximize payment accuracy for genetic testing claims.

Lyric, a leading claims editing software business owned by TPG Capital, today announced the appointment of Raj Ronanki as Chief Executive Officer. Ronanki most recently served as Senior Vice President of Elevance Health and President of Carelon Digital Platforms.